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INTRODUCTION
Renal ischemia-reperfusion (I/R) injury leads to acute 
renal damage, acute renal failure (ARF) and chronic renal 
failure. I/R injury is often seen in intensive care units, 
secondary to trauma, shock, sepsis, renal transplantation, 
cardiovascular and urologic surgery [1,2]. ARF can be seen 
in 5% of hospitalized patients and approximately 10% of 
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these patients will need renal transplantation [3]. Also ARF 
patients had more than 2 days of  hospitalization when 
compared to patients without ARF and mortality rates are 4.1 
times higher [4]. In renal transplantation I/R injury usually 
leads to primary renal dysfunction, delayed graft failure, 
increased late acute rejection and allograft dysfunction [5,6]. 
In partial nephrectomy, renal arteries are clamped before 
tumor removal and during this time I/R injury leads to 
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functional renal tissue damage [7].
The pathogenesis of  I/R injury is not defined clearly 
and several independent multifactorial mechanisms play a 
role in this process. During ischemia tissue blood flow and 
oxygen levels decrease and cellular damage occurs depending 
on the duration and the severity of ischemia. 
During reperfusion ischemic tissue is supported by 
blood flow but paradoxically leads to additional damage 
[8-10]. In I/R injury reactive oxygen radicals and the 
acute inflammatory process are the main factors causing 
the damage. The most sensitive cellular structures are 
membrane lipids, proteins, nucleic acids and DNA molecules 
[11].
Mannitol is an osmotic diuretic and used to prevent 
acute renal injury because of its potential renal protective 
effect. This renoprotective effect is provided by the removal 
of  obstructing tubular casts, dilution of  nephrotoxic 
substances in the tubular fluid and reduction in the swelling 
of  tubular elements via osmotic extraction of  water [12]. 
Also mannitol increases renal blood flow and consequently 
clears free radicals during the reperfusion period [12]. Some 
studies have shown that the prophylactic administration of 
mannitol reduces renal damage however some other studies 
have reported that it has no benefit at all and there are also 
other studies showing that it increases renal damage [12,13].
Nitric oxide (NO) has a pivotal role in I/R injury which 
is relatively complicated. Indictable nitric oxide synthases 
are related to the damage and endothelial NOS (eNOS) has 
protective effects. Udenafil is a phosphodiesterase type 5 
(PDE-5) inhibitor and increases the level of cyclic guanosine 
monophosphate which is the second messenger for NO and 
eNOS. Also udenafil was known to have fixed and consistent 
pharmacokinetics in rats and have been used orally in the 
previous experimental studies for similar purposes [14,15].
The aim of this study was to compare the renoprotective 
effects of mannitol and udenafil on renal I/R injury in an 
experimental model which may potentially help the field 
of deceased donor transplantation and partial nephrectomy 
where clamping is required.
MATERIALS AND METHODS
This study was approved by the Pamukkale University 
Animal Ethics Committee. Sixty-four female Wistar Albino 
rats weighing 281–330 g were randomly divided into 4 
groups. Right nephrectomy was performed in all groups. 
Left kidney remained intact and no additional procedures 
were performed in the control group. In I/R groups left renal 
artery was occluded by a vascular clamp for 45 minutes 
and the clamp was removed for reperfusion for 60 minutes 
(n=8) and 24 hours (n=8) for short-term effects of I/R injury 
and functional studies, respectively. In the mannitol group; 
1 mL 20% mannitol was given intravenously 15 minutes 
before clamping and same procedures were performed, as 
mentioned above. In the udenafil group; 10-mg/kg udenafil 
was given orally 1 hour before clamping with an orogastric 
tube and the procedure was repeated. At the end of  the 
60 minutes reperfusion period left nephrectomy was 
performed and tissue samples were divided into 3 pieces for 
biochemical, histopathological and comet assay examinations. 
Urine samples were collected by intravesical aspiration and 
blood samples were collected by intracardiac aspiration. In 
24-hour reperfusion groups, rats were placed into metabolic 
cages after anesthesia recovery. At the end of the 24-hour 
reperfusion period rats were reanesthetized and blood and 
urine samples were collected. Tissue samples were kept at 
-80°C, blood and urine samples were centrifuged and kept at 
-20°C.
1. Functional and biochemical studies
1) Determination of serum Cr, BUN, urine Cr, and 
Cr clearance
Serum creatinine (Cr), blood urea nitrogen (BUN), and 
urine Cr levels were calculated with the automatic sys-
tem at Pamukkale University Medical Faculty Hospital 
Biochemistry Laboratory. Cr clearance was calculated by 
using the formula: urine Cr×24-hour urine volume/serum 
Cr×1440. Serum Cr levels were indicated as ''Day 0'' 45 
minutes ischemia and 60 minutes reperfusion period and 
''Day 1'' 45 minutes ischemia and 24 hours reperfusion period.
2) Determination of MDA level
Samples of malondialdehyde (MDA) were prepared by 
standards in the prospectus of  lipid peroxidation (MDA) 
Colorimetric/FluoROMetric Assay Kit product by BioVision. 
Results were collected by spectrophotometric measurement 
of the color generated by the reaction of thiobarbituric acid 
(TBARS) with MDA.
3) Determination of NGAL (lipocalin 2) level
Samples were diluted 1:10 as calculation of  medium 
target protein concentration was aimed. Standard and 
controls were prepared according to the instructions of 
Boster Immunoleader Rat Lipocalin-2/neutrophil gelatinase 
associated lipocalin (NGAL) ELISA Kit. NGAL antibody, 
Avidin-Biotin-Peroxidase Complex (ABC), phosphate buffer 
saline (PBS) were also prepared. TMB (3,3’,5,5’-Tetramethyl
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benzidine) color developing agent and TMB stop solutions 
were used as ready-to-use products. Then 0.1 mL of standard, 
control, blind and samples were put into the plates and 
incubated at 37°C for 90 minutes. Biotinized antibodies were 
added and incubated at 37°C for 60 minutes. Plates were 
washed 3 times with 0.01M PBS. Then ABC working solution 
was added and incubated at 37°C for 30 minutes. Plates were 
washed 5 times with 0.01M PBS. TMB color developing agent 
was added and incubated at 37°C for 30 minutes in dark 
room. TMB stop solution was added. Absorbance values was 
read at 450 nm wavelength with Kayto RT-2100c Microplate 
Reader device.
4) Preparation of tissues for comet assay (single-
cell electrophoresis)
Comet sampling was performed by using Cell Biolabs 
OxiSelect Comet Assay Kit and Santacruz cOmPlete EDTA-
Free protease inhibitor cocktail tablets. DNA damage was 
determined by using the program Comet Assay IV system 
(AutoComet) by one physiologist blindly.
5) Histopathological examination
The histopathological examinations were performed, and 
the findings were scored by the same pathologist blindly as 
described in the study of Medeiros et al. [16]. Scores used for 
histopathological evaluation are shown in Table 1.
2. Statistical analysis
All data were expressed as the mean±standard deviation. 
Differences between groups were evaluated by Kruskal-
Wallis variance analysis followed by a Mann-Whitney U-test 
with Bonferroni correction for binary comparisons. The 
Pearson chi-square test was used to compare renal pathology 
grades. Values of p<0.05 were considered statistically signi-
ficant. All data were processed using the SPSS ver. 17.0 (SPSS 
Inc., Chicago, IL, USA) statistical package.
RESULTS
Serum Cr levels of the udenafil and mannitol groups 
on day 0 and day 1 were found to be lower than the I/
R group. This decrease was significant for the udenafil 
group (Fig. 1, Table 2). Also, an increase in serum Cr was 
observed for all groups on the 1st day and for the udenafil 
group the rate of increase was minimum. (control=40%, I/
R=64%, mannitol=57%, udenafil=35%). When the serum 
BUN levels of the groups were compared to the I/R group, 
results were detected higher for the mannitol group and in 
contrast significantly lower for the udenafil group (Table 
2). When Cr clearance levels of the groups were compared, 
I/R group had the lowest Cr clearance. Cr clearance was 
detected higher for the mannitol and udenafil groups. Cr 
clearance for udenafil group was detected higher than both 
the I/R and mannitol groups, and these findings were also 
statistically significant (Fig. 1, Table 2).
The serum and tissue MDA levels were the highest in 
the I/R group and MDA levels were found significantly 
lower for both the mannitol and udenafil groups (Table 2). 
The serum, urine and tissue NGAL levels were detected 
Table 1. Scores used for histopathological evaluation
Score Histopathological pattern
0 Normal
0.5 Small focal injured areas
1 <10% Cortical injured zone
2 10% to 25% Cortical injured zone
3 25% to 75% Cortical injured zone
4 >75% Cortical injured zone
Fig. 1. Creatinine and creatinine clearance levels of the control and the study groups. I/R, ischemia-reperfusion; M, mannitol; U, udenafil. *Statiscally sig-
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higher in the I/R group. NGAL levels were detected lower 
for mannitol and udenafil groups and this decrease was 
significant for the udenafil group (Table 2).
When pathological damage rates of the groups examined, 
acute damage rate was detected the highest for the mannitol 
group. Damage rate was detected lower for the udenafil 
group (Table 2).
In the comet assay examination of  the groups no 
significant difference was detected after the evaluation of 
head intensity, tail intensity, and tail length (Table 2).
DISCUSSION
For many years in practice mannitol has been widely 
used for decreasing ARF in intensive care units and surgical 
operations. However, its effectiveness has become highly 
questionable after recent studies [13]. Tissue protective effects 
of PDE-5 inhibitors have been shown on kidney and other 
organs against I/R injury. Udenafil which is a new member 
of  the PDE-5 family has also proved its effectiveness in 
preventing the renal I/R injury [14]. Although both of 
mannitol and udenafil have been shown to be effective 
separetely and mannitol is widely used in daily practice, 
there have been no studies comparing the effects of these 
agents. This is the first study comparing the efficacy of both 
the mannitol and udenafil in an I/R experimental model. 
Additionally, comet-assay method which is an indicator of 
DNA damage has been used for evaluation of tissue damage 
in such a model for the first time.
The effectiveness of several PDE-5 inhibitors including 
sildenafil, tadalafil, udenafil and zaprinast for preventing 
the renal damage caused by I/R were investigated before. In 
several studies recovery of renal function was shown with 
the decrease in Cr and BUN levels, increase in glomerular 
filtration rate (GFR) or by using scintigraphic studies [15-
18]. The positive and renoprotective effects of  mannitol 
were also shown by Burke et al. [19] and Dawson [20] in the 
acute renal damage models. We detected that there was an 
improvement in renal function parameters in mannitol and 
udenafil groups which was consistent with those studies and 
this improvement was significantly higher in the udenafil 
group compared to the mannitol group which was not 
demonstrated previously.
NGAL can be detected in the urine in the second hour 
after ischemic renal damage and its level continue to rise 
proportionally with the intensity of damage. Also it is an 
indicator which can be detected in the serum before the Cr 
level increases. In an experimental renal I/R injury model, 
NGAL and kidney injury molecule levels decreased with 
a concordant increase in GFR levels in the group treated 
with tadalafil [18]. A significant difference in the NGAL 
levels was also demonstrated in studies investigating the 
effects of renal transplantation. NGAL levels of the patients 
who had transplantation and the patients who are waiting 
for transplantation have been found to be significantly 
higher than the healthy population (7,6 fold and 9 fold, 
respectively). Twelve months later, a considerable decrease 
in the NGAL levels (1.5 times the healthy population) has 
been detected in transplantation group when compared 
to the patients who were on the waiting list (10 times the 
Table 2. The results of functional, biochemical and pathological examinations in control and study groups
Variable Control I/R M U p-value
Creatinine (Day 0) (mg/dL) 0.40±0.11 0.77±0.18c 0.65±0.18c 0.52±0.11a 0.001
Creatinine (Day 1) (mg/dL) 0.56±0.31 1.27±0.44c 1.04±0.47 0.72±0.24a 0.003
Creatinine clearance (mL/min) 0.64±0.27 0.12±0.06c 0.26±0.12c 0.41±0.07a,b 0.000
BUN (mg/dL) 53.03±7.73 75.90±14.61c 78.52±13.18c 56.17±9.36a,b 0.001
MDA tissue (nmol/mL) 16.50±5.60 44.07±8.48c 18.15±5.24a 16.81±5.41a 0.000
MDA serum (nmol/mL) 1.92±0.06 2.19±0.10c 1.96±0.09a 1.93±0.04a 0.001
NGAL tissue (pg/mL) 94.51±5.71 115.58±9.16c 106.03±7.00c 101.42±6.38a 0.000
NGAL serum (pg/mL) 2.70±0.15 5.27±1.43c 3.04±0.29a,c 2.80±0.10a 0.000
NGAL urine (pg/mL) 14.76±2.02 48.31±4.82c 30.25±3.39a,c 23.46±4.00a,b,c 0.000
Pathology 1.25±0.70 3.37±0.74 3.75±0.46 2.87±0.83b 0.000
Comet assay head index (%) 99.55±0.53 92.18±9.10c 93.80±8.03 99.33±1.22 0.012
Comet assay tail index (%) 1.24±2.28 2.08±1.51 1.53±1.53 1.65±1.49 0.343
Comet assay tail length (μm) 2.04±0.80 2.45±1.02 2.50±1.29 2.20±1.02 0.763
I/R, ischemia-reperfusion; M, mannitol; U, udenafil; BUN, blood urea nitrogen; MDA, malondialdehyde; NGAL, neutrophil gelatinase associated 
lipocalin.
a:Statistically significant (p<0.01) when U and M groups compared to I/R group. b:Statistically significant (p<0.01) when U group compared to M 
group. c:Statistically significant (p<0.01) when U, M and I/R groups compared to control group.
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healthy population) [21]. In our study, tissue NGAL level was 
found to be highest in the I/R group, and this difference was 
statistically significant when compared to the control group. 
Tissue NGAL levels of the udenafil and mannitol groups 
were determined to be lower the I/R group. The decrease 
in the udenafil group was more explicit and found to be 
statistically significant. We also showed that the increase 
in the tissue NGAL level starts within the first 60 minutes 
with the damage occurring after the reperfusion. In our 
study, the serum and urine NGAL level after reperfusion 
was detected highest in the I/R group. The serum and 
urine NGAL levels in the udenafil and mannitol groups 
were considerably lower when compared to the I/R group. 
Although not statistically significant the serum NGAL level 
of the udenafil group was detected to be lower than the 
mannitol group. 
Free oxygen radicals arise with the I/R injury and cause 
damage to membrane lipids. Lipid peroxidation is linked 
to tissue damage, and MDA is an indicator that brings out 
lipid peroxydation. Kucuk et al. [22] have compared the 
effectiveness of sildenafil and tadalafil which are inhibitors 
of PDE5 in the renal I/R injury model. In their study, they 
have found that both of the PDE5 inhibitors have decreased 
the tissue MDA level more than the I/R group and that this 
effect is better in the sildenafil group. Fu et al. [23] made by 
using L-citrulline in the study, have shown a considerable 
increase in tissue MDA levels. They have found that MDA 
levels have decreased significantly in the L-citrulline group. 
In accordance with the previous studies, our study showed 
that both mannitol and udenafil decreases the MDA level 
and inhibits lipid peroxidation.
The alterations in renal histopathology in renal I/
R models have also been investigated. In previous studies 
investigating the effects of  different agents including 
PDE-5 inhibitors, several authors showed that there was 
a considerable decrease of  damage in treatment groups 
compared to the I/R groups [16,17,24-26]. In our study, the 
histopathological renal damage in the early period was 
found to be higher in the I/R, mannitol and udenafil groups 
when compared to the control group. Although the level 
of damage in the I/R and mannitol groups more obvious 
and the level of damage in the udenafil group is less when 
compared to the I/R and mannitol groups, the difference 
was not statistically significant.
One of  the important effects of  I/R injury occurs on 
DNA which was shown in previous studies. Dias et al. [27] 
have studied the effects of sildenafil on oxidative stress, 
DNA damage and renal functions in an experimental 
renovascular hypertension model. When comparing mea-
sure ments of  tail density and tail momentum in Comet 
sampling analysis, a significant increase (2 fold) in DNA 
damage in the placebo group was demonstrated when 
compared to the group treated with sildenafil. In the current 
study we have found that in the mannitol group and the 
udenafil group, DNA damage was lower. The difference in 
the udenafil group was significant. Karahalil et al. [28] have 
examined the I/R injury related DNA damage that occurs 
in preischemia, postischemia, and postreperfusion of patients 
who have had lower extremity surgery. In the Comet 
sampling analysis, tail density between the groups has been 
examined, and it has been found that that there was no 
significant difference among the 3 groups. In our study, 
looking at the most important parameter, the tail density, 
the differences were not found to be significant although 
there was an increase in density in the I/R group and a 
decrease in the mannitol and udenafil groups. According 
to the results obtained from the post I/R Comet sampling 
analysis, no significant DNA damage has occurred in tissue 
cells. The reason of that may be cytotoxic damage did not 
reach to genotoxic levels or the lack of Comet Assay method 
to detect renal tissue genotoxic damage.
Although routinely used in daily practice to prevent 
ischemia-related injury during partial nephrectomy in 
urology clinics, there are controversies regarding mannitol. 
In their review, Hersey and Poullis [29] have investigated the 
effects of mannitol use in open abdominal aortic aneurysm 
surgeries on the protection of kidneys. In some of the studies 
included in that review, it is revealed that mannitol causes 
a remission in the renal functions during the acute stage, 
but it does not affect the overall renal failure incidence. 
Power et al. [30] have investigated the effects of mannitol 
use before partial nephrectomy ischemia on renal functions. 
Considering the long-term effects (after at least six months), 
they have concluded that the patients using mannitol do not 
exhibit a significant difference regarding renal functions 
as compared to the patients who were not administered 
mannitol. Karajala et al. [12] have revealed in their study 
that diuretic agents including mannitol, are not to be used 
for protective purposes; they are to be used merely to set 
the liquid balance in treatment. In another meta-analysis, 
the use of  mannitol did not have additional benefits in 
decreasing acute renal damage of the patients who received 
adequate fluid treatment. Also, mannitol was proved to 






This study showed that udenafil improves renal func-
tions, decreases lipid peroxidation and reduces histological 
and DNA damage in the renal I/R injury models. It has 
significantly better effects on decreasing renal damage than 
mannitol which is currently most widely used agent for the 
same purposes. The use of other phosphodiesterase type-5 
inhibitors in other studies revealed similar results. Although 
previous studies have shown these effects separately with 
various agents including different PDE-5 inhibitors, to our 
knowledge our study is the first demonstrating a wide range 
of biochemical, histological and ultrastructural changes in 
an experimental I/R injury model. Also, as an experimental 
study, our results show the short term effects of both agents. 
To support the short term effects and to investigate the long 
term effects, further experimental and clinical trials are 
needed. 
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